BiotechTube

losartan (drug)

ApprovedUNKNOWN
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Alcoholic Liver Cirrhosis

Conditions

Alcoholic Liver Cirrhosis, Ascites

Trial Timeline

Sep 1, 2005 → Sep 1, 2011

NCT ID
NCT00239096

About losartan (drug)

losartan (drug) is a approved stage product being developed by Lundbeck for Alcoholic Liver Cirrhosis. The current trial status is unknown. This product is registered under clinical trial identifier NCT00239096. Target conditions include Alcoholic Liver Cirrhosis, Ascites.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00239096ApprovedUNKNOWN

Competing Products

20 competing products in Alcoholic Liver Cirrhosis

See all competitors
ProductCompanyStageHype Score
VK2809 + PlacebosViking TherapeuticsPhase 2
47
TERN-501 + TERN-101Terns PharmaceuticalsPhase 2
49
TERN-101Terns PharmaceuticalsPhase 2
49
TERN-201Terns PharmaceuticalsPhase 1
30
IVA337 + IVA337 + PlaceboInventivaPhase 2
47
LanifibranorInventivaPhase 2
47
IVA337 + Placebo + EmpagliflozinInventivaPhase 2
47
IVA337 + PlaceboInventivaPhase 3
72
GODEX + PlaceboCelltrionPhase 3
77
Colesevelam HclDaiichi SankyoPhase 2
52
ASP9831 + PlaceboAstellas PharmaPhase 2
52
Tirzepatide + PlaceboEli LillyPhase 2
52
AZD9550 + AZD9550 + PlaceboAstraZenecaPhase 1
33
AZD2693AstraZenecaPhase 1
33
placebo + Omega-3 carboxylic acids + Dapagliflozin + PlaceboAstraZenecaPhase 2
52
AZD4831AstraZenecaPhase 2
52
AZD2693AstraZenecaPhase 2
52
AZ compoundAstraZenecaPhase 2
52
cotadutide solution for injectionAstraZenecaPhase 1
33
Cotadutide + Cotadutide-placebo + Moxifloxacin + Moxifloxacin-placeboAstraZenecaPhase 1
33

Other Products from Lundbeck

VortioxetineApproved
82
memantine + memantine + placeboApproved
82
escitalopram + escitalopramApproved
82
BrexpiprazoleApproved
82
vigabatrinApproved
82